ACM Biolabs
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally. (NCT05385991) | ACM Biolabs | 2022-07-01 |
Track ACM Biolabs automatically
Every clearance here is in the API, with alerts when new ones post.